OneDigital Investment Advisors LLC Makes New $1.57 Million Investment in Cencora, Inc. $COR

OneDigital Investment Advisors LLC bought a new position in shares of Cencora, Inc. (NYSE:COR) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 5,561 shares of the company’s stock, valued at approximately $1,574,000.

Other large investors have also recently made changes to their positions in the company. ExodusPoint Capital Management LP bought a new position in shares of Cencora during the 4th quarter worth $16,487,000. Impact Partnership Wealth LLC purchased a new position in shares of Cencora during the first quarter valued at $1,170,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Cencora by 162.4% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 289,370 shares of the company’s stock valued at $97,735,000 after acquiring an additional 179,086 shares in the last quarter. SEB Asset Management AB bought a new stake in shares of Cencora in the first quarter valued at about $134,139,000. Finally, PFA Pension Forsikringsaktieselskab purchased a new stake in Cencora in the fourth quarter worth about $59,145,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Cencora news, Director Lauren M. Tyler bought 550 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the purchase, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.38% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on COR. Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 6th. JPMorgan Chase & Co. boosted their price target on shares of Cencora from $382.00 to $390.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Barclays lowered their price target on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, June 10th. Evercore reiterated an “outperform” rating and set a $350.00 price objective on shares of Cencora in a research note on Thursday, August 6th. Finally, Wells Fargo & Company lifted their price objective on shares of Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a report on Tuesday, August 11th. Thirteen research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $374.25.

Cencora Stock Performance

Shares of Cencora stock opened at $312.51 on Tuesday. The company has a market capitalization of $59.64 billion, a PE ratio of 23.22, a P/E/G ratio of 1.80 and a beta of 0.57. The company has a 50-day simple moving average of $299.75 and a two-hundred day simple moving average of $312.64. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, topping the consensus estimate of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The firm had revenue of $84.75 billion during the quarter, compared to analyst estimates of $84.31 billion. During the same quarter in the previous year, the business posted $4.00 EPS. Cencora’s revenue was up 5.1% on a year-over-year basis. Research analysts expect that Cencora, Inc. will post 17.84 EPS for the current fiscal year.

Cencora announced that its Board of Directors has authorized a stock repurchase program on Thursday, May 21st that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be given a $0.60 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. Cencora’s dividend payout ratio (DPR) is presently 17.83%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.